Pressure BioSciences, Inc.
PBIO
$0.0031
-$0.002-39.22%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.80% | -17.74% | -122.14% | -26.17% | -137.38% |
| Total Depreciation and Amortization | 219.22% | 169.75% | -45.75% | 384.48% | 3.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -10.94% | -4.20% | 227.92% | 83.07% | 287.16% |
| Change in Net Operating Assets | 110.08% | -4.12% | 111.61% | -36.03% | 163.11% |
| Cash from Operations | 21.50% | -340.45% | 20.65% | 30.45% | 27.59% |
| Capital Expenditure | -- | -- | -- | 71.70% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 71.70% | 100.00% |
| Total Debt Issued | -52.11% | -31.11% | -30.83% | -50.69% | -13.06% |
| Total Debt Repaid | 77.38% | 83.25% | 61.19% | 66.46% | -18.50% |
| Issuance of Common Stock | -- | -- | -100.00% | -- | 187.36% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.64% | 169.76% | 0.70% | -39.13% | -45.12% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 105.14% | -133.21% | 133.48% | -118.02% | -7,742.86% |